Corona vaccine has become a major source of income, you will be surprised to know –

While the global Corona virus epidemic has severely affected the livelihoods of millions of people, leaving no one behind.

Leading the way are the pharmaceutical companies that developed the Corona vaccine and sold it in the market, which led to a huge increase in their profits.

Only three major companies are making huge profits of one thousand dollars (approximately 175,000 Pakistani rupees) per second from the sale of vaccines designed to fight the global epidemic Corona virus.

A report released by the People’s Vaccine Alliance states that Pfizer, Bio-N Tech and Modern Corona vaccines alone are making a whopping ڈالر 1,000 a second, according to a report in The Economic Times. Are

According to the report, these companies have sold most of their vaccines to countries which are considered to be very rich.

It should be noted that the World Health Organization had warned some time ago that it has become very difficult to get vaccines in low income and poor countries due to which it is feared that a large population will not be able to get the required food.

The People’s Vaccine Alliance report claims that the three companies will have made a whopping ارب 34 billion in profits before paying taxes this year.

According to the statistics, the three companies are earning only one thousand dollars per second, 65 thousand dollars per minute and 93.5 million dollars per day.

According to the report, Pfizer and BioNTic provided less than one percent of their total supply to poor countries, while Moderna provided only 0.2 percent to low-income countries.

Read Also:  Where To Get Free Copies Of Your Credit Reports

It should be noted that according to the released data, 98% of the people in low income countries are not fully vaccinated.

The World Health Organization has also asked Pfizer, Biotech and Modern to provide their vaccine technology to low- and middle-income countries.

Despite the hefty funding of 8 billion, these companies rejected the request and did not comply.

Comments

Recent Articles

Related News

Leave A Reply

Please enter your comment!
Please enter your name here